Clostridium Difficile and Inflammatory Bowel Disease

被引：49
|
作者：
Ananthakrishnan, Ashwin N. [2 ]
Issa, Mazen [2 ]
Binion, David G. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, UPMC IBD Ctr, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
[2] Med Coll Wisconsin, Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA
来源：
GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2009年 / 38卷 / 04期
关键词：
Clostridium difficile; Inflammatory bowel disease; Crohn disease; Ulcerative colitis; Colectomy; TOXIN-A; PSEUDOMEMBRANOUS COLITIS; RISK-FACTORS; DIARRHEA; INFECTION; VANCOMYCIN; METRONIDAZOLE; DIAGNOSIS; ENTERITIS; OUTBREAK;
D O I：
10.1016/j.gtc.2009.07.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The past decade has seen an alarming increase in the burden of disease associated with Clostridium difficile. Several studies have now demonstrated an increasing incidence of C difficile infection in patients with inflammatory bowel disease (IBD) with a more severe course of disease compared with the non-IBD population. This article summarizes the available literature on the impact of C difficile infection on IBD and discusses the various diagnostic testing and treatment options available. Also reviewed are clinical situations specific to patients with IBD that are important for the treating physician to recognize.
引用
收藏
页码：711 / +
页数：19
相关论文
共 50 条
  • [31] Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
    Nancy Fu
    Titus Wong
    Current Infectious Disease Reports, 2016, 18
  • [32] Clostridium difficile Infection and Inflammatory Bowel Disease: A Review
    Sinh, Preetika
    Barrett, Terrence A.
    Yun, Laura
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2011, 2011
  • [33] Clostridium difficile Infection in the Inflammatory Bowel Disease Patient
    Berg, Adam M.
    Kelly, Ciaran P.
    Farraye, Francis A.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (01) : 194 - 204
  • [34] Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
    Albarrak, Abdulmajeed A.
    Romana, Bhupinder S.
    Uraz, Suleyman
    Yousef, Mohamad H.
    Juboori, Alhareth A.
    Tahan, Veysel
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (07) : 929 - 935
  • [35] Clostridium difficile infection in inflammatory bowel disease and non-inflammatory bowel disease patients
    Stoica, O.
    Stanciu, C.
    Cojocariu, C.
    Singeap, A. -M.
    Girleanu, I.
    Maxim, R.
    Trifan, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S425 - S425
  • [36] CLOSTRIDIUM-DIFFICILE IN INFLAMMATORY BOWEL-DISEASE RELAPSE
    GRYBOSKI, JD
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1991, 13 (01): : 39 - 41
  • [37] Antibodies to Clostridium difficile Toxins in Inflammatory Bowel Disease Patients
    Berg, Adam
    Qazi, Taha
    Wasan, Sharmeel
    Calderwood, Audrey
    Villafuerte-Galvez, Javier
    Kelly, Ciaran
    Farraye, Francis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S616 - S616
  • [38] Prognosis in Clostridium difficile infection complicating inflammatory bowel disease
    Stone, Christian D.
    GUT, 2008, 57 (02) : 150 - 152
  • [39] Clostridium difficile infection and inflammatory bowel disease:: a marker for disease extent?
    Powell, N.
    Jung, S. E.
    Krishnan, B.
    GUT, 2008, 57 (08) : 1183 - 1184
  • [40] CLOSTRIDIUM DIFFICILE SCREENING IN HOSPITALIZED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Gagnon-Jacques, Ariane
    Cote-Daigneault, Justin
    GASTROENTEROLOGY, 2019, 156 (06) : S673 - S673
12345